Safety and Efficacy of ZTI-01 (IV Fosfomycin) vs Piperacillin/Tazobactam for Treatment cUTI/AP Infections

NCT02753946 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

465

Enrollment

INDUSTRY

Sponsor class

Conditions

Urinary Tract Infection Symptomatic
Acute Pyelonephritis
Urinary Tract Infection Complicated

Interventions

DRUG: ZTI-01
DRUG: Piperacillin-tazobactam

Sponsor

Nabriva Therapeutics AG

Collaborators

[object Object]